A compound represented by the following formula ##STR1## wherein X.sup.1 and X.sup.2 are identical or different and each represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a halogen atom, a trifluoromethyl group or a trifluoromethoxy group; Y.sup.1 and Y.sup.2 are identical or different and each represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a cyano group, a nitro group, a halogen atom or a trifluoromethyl group; Z represents an oxygen or sulfur atom; and n is 0 or 1; excepting the case where n is 0 and X.sup.1 and X.sup.2 are both hydrogen atoms, the case where n is 1 and X.sup.1 and X.sup.2 are members selected from the class consisting of hydrogen and halogen (excepting iodine) atoms, and the case where Y.sup.1 and Y.sup.2 are membrs selected from the class consisting of hydrogen and halogen (excepting iodine) atoms and nitro groups. This compound is useful as an insecticidal and acaricidal (miticidal) agent.
PREPARATION OF N-ARYLMETHYL AZIRIDINE DERIVATIVES, 1,4,7,10-TETRAAZACYCLODODECANE DERIVATIVES OBTAINED THEREFROM AND N-ARYLMETHYL-ETHANOL-AMINE SULPHONATE ESTERS AS INTERMEDIATES
申请人:NYCOMED SALUTAR INC.
公开号:EP0813523A2
公开(公告)日:1997-12-29
OX2R Compounds
申请人:Board of Regents, The University of Texas System
公开号:US20210107914A1
公开(公告)日:2021-04-15
Methods and compositions for agonizing a type-2 orexin receptor (OX2R) in a cell determined to be in need thereof, including the general method of (a) administering to a subject a cyclic guanidinyl OX2R agonist and (b) detecting a resultant enhanced wakefulness or increased resistance to diet-induced accumulation of body fat, or abbreviated recovery from general anesthesia or jet lag.